Literature DB >> 21275269

Risk factors for persistent gestational trophoblastic neoplasia.

Umur Kuyumcuoglu1, Ali Irfan Guzel, Mahmut Erdemoglu, Yusuf Celik.   

Abstract

This retrospective study evaluated the risk factors for persistent gestational trophoblastic disease (GTN) and determined their odds ratios. This study included 100 cases with GTN admitted to our clinic. Possible risk factors recorded were age, gravidity, parity, size of the neoplasia, and beta-human chorionic gonadotropin levels (beta-hCG) before and after the procedure. Statistical analyses consisted of the independent sample t-test and logistic regression using the statistical package SPSS ver. 15.0 for Windows (SPSS, Chicago, IL, USA). Twenty of the cases had persistent GTN, and the differences between these and the others cases were evaluated. The size of the neoplasia and histopathological type of GTN had no statistical relationship with persistence, whereas age, gravidity, and beta-hCG levels were significant risk factors for persistent GTN (p < 0.05). The odds ratios (95% confidence interval (CI)) for age, gravidity, and pre- and post-evacuation beta-hCG levels determined using logistic regression were 4.678 (0.97-22.44), 7.315 (1.16-46.16), 2.637 (1.41-4.94), and 2.339 (1.52-3.60), respectively. Patient age, gravidity, and beta-hCG levels were risk factors for persistent GTN, whereas the size of the neoplasia and histopathological type of GTN were not significant risk factors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21275269

Source DB:  PubMed          Journal:  J Exp Ther Oncol        ISSN: 1359-4117


  2 in total

1.  Does Postevacuation β -Human Chorionic Gonadotropin Level Predict the Persistent Gestational Trophoblastic Neoplasia?

Authors:  Azam Sadat Mousavi; Samieh Karimi; Mitra Modarres Gilani; Setareh Akhavan; Elahe Rezayof
Journal:  ISRN Obstet Gynecol       Date:  2014-03-24

2.  Implementation and Monitoring of a Gestational Trophoblastic Disease Management Program in a Tertiary Hospital in Morocco: Opportunities and Challenges.

Authors:  Imane Khachani; Mohamed Hassan Alami; Rachid Bezad
Journal:  Obstet Gynecol Int       Date:  2017-04-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.